FDA Approved Cannabinoid Research with Dr. Jennifer Triemstra: Separating Fact from Fiction
Episode Overview
Understanding the crucial disparities between FDA approved medications and unregulated consumer-grade cannabis products Advocating for an educated discussion and decision-making process Shedding light on the complexities of cannabinoid science and the endocannabinoid system Addressing the lack of consistent testing requirements in the commoditized cannabis market Empowering listeners to seek credible resources and remain informed consumers of CBD products and other cannabinoids
Having an educated discussion is what's going to lead to an educated decision. And I want all of us to be empowered with education to make that right educated decision, but what we're going to do with these cannabinoids and how we're going to use them.
Have you ever wondered about the real differences between FDA approved cannabinoid medications and the cannabis products you see on store shelves? In this episode of 'High Truths on Drugs and Addiction', Dr. Roneet Lev sits down with Dr. Jennifer Triemstra, an expert in cannabinoid science, to unravel these complexities. Dr. Triemstra, who has spent nearly seven years in the field, shares her insights on the pharmaceutical benefits of cannabinoids and the rigorous testing they undergo to gain FDA approval.
Trie, as she's affectionately known, highlights the stark contrast between well-regulated, FDA approved therapies and the often inconsistent quality of consumer-grade cannabis products. She discusses the endocannabinoid system and how it interacts with different cannabinoids, providing a clearer understanding of why not all cannabis products are created equal. The conversation also touches on the 'buyer beware' state of the current cannabis market, emphasizing the importance of consumer education. Dr.
Triemstra encourages listeners to seek out credible information and make informed decisions when it comes to using CBD and other cannabinoids. Whether you're curious about the medical applications of cannabinoids or concerned about the safety of over-the-counter cannabis products, this episode offers valuable insights that can help you navigate this complex landscape.